News

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
Anne Wojcicki to buy back 23andMe and its data for $305 million
Anne Wojcicki's nonprofit will acquire substantially all of 23andMe's assets for $305 million, the company announced Friday.
Anne Wojcicki is taking back control of 23andMe
Wojcicki, a co-founder and former CEO of 23andMe, is buying ‘substantially all’ of the company’s assets through a nonprofit.
How to delete your 23andMe data
To delete your data from 23andMe, you need to log in to your account and then follow these steps: Navigate to the Settings ...